{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "COVID-19",
      "Clinical outcomes",
      "Coronavirus",
      "Gender bias",
      "Sex differences"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33903964",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "08"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "11",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "26"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/s00296-021-04873-9"
    ],
    "Journal": {
      "ISSN": "1437-160X",
      "JournalIssue": {
        "Volume": "41",
        "Issue": "8",
        "PubDate": {
          "Year": "2021",
          "Month": "Aug"
        }
      },
      "Title": "Rheumatology international",
      "ISOAbbreviation": "Rheumatol Int"
    },
    "ArticleTitle": "Sex hormones, autoimmunity and gender disparity in COVID-19.",
    "Pagination": {
      "StartPage": "1375",
      "EndPage": "1386",
      "MedlinePgn": "1375-1386"
    },
    "Abstract": {
      "AbstractText": [
        "The Coronavirus disease 2019 (COVID-19) pandemic has majorly contributed to massive and widespread mortality. Epidemiological data strongly indicates a sex-based disparity in COVID-19 clinical outcomes, with women having lower infection and hospitalisation rates, coupled with better prognosis and lesser mortality. This disparity may be explained by several mechanisms including differences in innate and adaptive immune responses, genetic factors, and an interplay between sex hormones and immune effectors, as well as gender-specific behaviour differences. These pathways, particularly the immunological divergence in response to viral infection, could potentially influence not only COVID-19 pathogenesis and disease course, but also the response to antiviral drugs and vaccines. Furthermore, factors that confer a protective advantage against COVID-19 may be exploited to develop therapeutic strategies to improve clinical outcomes in COVID-19."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0002-0346-894X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical College, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan."
          }
        ],
        "LastName": "Raza",
        "ForeName": "Hussain Ahmed",
        "Initials": "HA"
      },
      {
        "Identifier": [
          "0000-0002-1630-6026"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Maulana Azad Medical College, 2-Bahadur Shah Zafar marg, New Delhi, India."
          }
        ],
        "LastName": "Sen",
        "ForeName": "Parikshit",
        "Initials": "P"
      },
      {
        "Identifier": [
          "0000-0003-4005-1104"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Medical College, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan."
          }
        ],
        "LastName": "Bhatti",
        "ForeName": "Omaima Anis",
        "Initials": "OA"
      },
      {
        "Identifier": [
          "0000-0003-2753-2990"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226014, India. drlatikagupta@gmail.com."
          }
        ],
        "LastName": "Gupta",
        "ForeName": "Latika",
        "Initials": "L"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "Rheumatol Int",
    "NlmUniqueID": "8206885",
    "ISSNLinking": "0172-8172"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Gonadal Steroid Hormones"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Autoimmunity"
    },
    {
      "QualifierName": [
        "epidemiology",
        "immunology",
        "metabolism",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Gonadal Steroid Hormones"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Health Status Disparities"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Host-Pathogen Interactions"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk Factors"
    },
    {
      "QualifierName": [
        "immunology",
        "metabolism",
        "pathogenicity"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sex Characteristics"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sex Factors"
    }
  ],
  "CoiStatement": "The authors declare that there is no conflict of interest."
}